Cytochroma's Series B - III Round

Cytochroma raised a round of funding on December 04, 2002. Investors include VenGrowth Capital Partners.

Cytochroma is a clinical-stage specialty pharmaceutical company focused on developing and commercializing products to treat and prevent the clinical consequences of vitamin D insufficiency and SHPT as…

Articles about Cytochroma's Series B - III Round: